ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling (ProTarget)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04341181 |
|
Recruitment Status :
Recruiting
First Posted : April 10, 2020
Last Update Posted : October 26, 2022
|
Sponsor:
Ulrik Lassen
Collaborators:
Roche Pharma AG
Pfizer
GlaxoSmithKline
Information provided by (Responsible Party):
Ulrik Lassen, Rigshospitalet, Denmark
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 30, 2024 |
| Estimated Study Completion Date : | April 30, 2025 |